Stock Financial Ratios


EYEG / Eyegate Pharmaceuticals Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price1.19
Volume256,900.00
Market Cap ($M)21.33
Enterprise Value ($M)-1.43
Book Value ($M)-0.33
Book Value / Share-0.04
Price / Book30.39
NCAV ($M)2.42
NCAV / Share0.27
Price / NCAV-3.97
Income Statement (mra) ($M)
Revenue0.67
EBITDA0.00
Net Income-13.34
Balance Sheet (mrq) ($M)
Cash & Equivalents9.24
Cash / Share1.05
Assets16.06
Liabilities15.38
Quick Ratio0.57
Current Ratio0.57
Management Effectiveness (mra)
Return on Invested Capital (ROIC)40.51
Return on Assets (ROA)-1.37
Return on Equity (ROE)40.51
Identifiers and Descriptors
CUSIP30233M107
Central Index Key (CIK)1372514
Industry Groups
SIC 2834 - Pharmaceutical Preparations
Share Statistics
Common Shares Outstanding (M)17.20
Scoring Models
Piotroski F Score3.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Treasury Stock Per Share0.00
Accounts Payable Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Inventory Per Share0.00
Assets Current Per Share1.16
Cash And Equivalents Per Share1.05
Liabilities And Stock Equity Per Share1.82
Inventory Work In Progress Per Share0.00
Goodwill Per Share0.00
Property Plant And Equipment Net Per Share0.00
Retained Earnings Per Share-10.07
Debt Per Share0.00
Assets Per Share1.82
Equity Per Share0.08
Liabilities Current Per Share1.43
Cash Per Share1.05
Deferred Income Tax Liabilities Per Share0.17
Assets Other Current Per Share0.00
Inventory Finished Goods Per Share0.00
Liabilities Other Non Current Per Share0.00
Liabilities Per Share1.74
Intangibles Per Share0.00
Accumulated Depreciation And Depletion Per Share0.00
Assets Other Non Current Per Share0.04
Minority Interest Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Property Plant And Equipment Gross Per Share0.00
Additional Paid In Capital Per Share10.12
Accounts Receivable Per Share0.00
Property Plant And Equipment Per Share0.00
Inventory Raw Materials Per Share0.00
Long Term Debt Per Share0.00

Related News Stories

BRIEF-EyeGate Achieves 75 Pct Enrollment In Pivotal Phase 3 Clinical Trial For Anterior Uveitis Triggering Milestone Payment

2017-12-18 reuters
* EYEGATE ACHIEVES 75% ENROLLMENT IN PIVOTAL PHASE 3 CLINICAL TRIAL FOR ANTERIOR UVEITIS TRIGGERING MILESTONE PAYMENT (12-1)

CUSIP: 30233M107